RNase 3 (ECP) is an extraordinarily stable protein among human pancreatic-type RNases

Takashi Maeda, Kazutoshi Mahara, Midori Kitazoe, Junichiro Futami, Aiko Takidani, Megumi Kosaka, Hiroko Tada, Masaharu Seno, Hidenori Yamada

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

There have been some attempts to develop immunotoxins utilizing human RNase as a cytotoxic domain of antitumor agents. We have recently shown that only human RNase 3 (eosinophil cationic protein, ECP) among five human pancreatic-type RNases excels in binding to the cell surface and has a growth inhibition effect on several cancer cell lines, even though the RNase activity of RNase 3 is completely inhibited by the ubiquitously expressed cytosolic RNase inhibitor. This phenomenon may be explained by that RNase 3 is very stable against proteolytic degradation because RNase 3 internalized through endocytosis could have a longer life time in the cytosol, resulting in the accumulation of enough of it to exceed the concentration of RNase inhibitor, which allows the degradation of cytosolic RNA molecules. Thus, we compared the stabilities of human pancreatic-type RNases (RNases 1-5) and bovine RNase A by means of guanidium chloride-induced denaturation experiments based on the assumption of a two-state transition for unfolding. It was demonstrated that RNase 3 is extraordinarily stabler than either RNase A or the other human RNases (by more than 25 kJ/mol). Thus, our data suggest that in addition to its specific affinity for certain cancer cell lines, the stability of RNase 3 contributes to its unique cytotoxic effect and that it is important to stabilize a human RNase moiety through protein engineering for the design of human RNase-based immunotoxins. Department of Bioscience.

Original languageEnglish
Pages (from-to)737-742
Number of pages6
JournalJournal of Biochemistry
Volume132
Issue number5
Publication statusPublished - Nov 1 2002

Fingerprint

Eosinophil Cationic Protein
Pancreatic Ribonuclease
Ribonucleases
Proteins
Immunotoxins
Protein Engineering
Cells
Cell Line
Degradation
Guanidine
RNA Stability
Denaturation
Endocytosis
Antineoplastic Agents
Cytosol
Corrosion inhibitors
Neoplasms
RNA
Molecules
Growth

Keywords

  • Cytotoxicity
  • ECP
  • RNase 3
  • Stability

ASJC Scopus subject areas

  • Biochemistry

Cite this

Maeda, T., Mahara, K., Kitazoe, M., Futami, J., Takidani, A., Kosaka, M., ... Yamada, H. (2002). RNase 3 (ECP) is an extraordinarily stable protein among human pancreatic-type RNases. Journal of Biochemistry, 132(5), 737-742.

RNase 3 (ECP) is an extraordinarily stable protein among human pancreatic-type RNases. / Maeda, Takashi; Mahara, Kazutoshi; Kitazoe, Midori; Futami, Junichiro; Takidani, Aiko; Kosaka, Megumi; Tada, Hiroko; Seno, Masaharu; Yamada, Hidenori.

In: Journal of Biochemistry, Vol. 132, No. 5, 01.11.2002, p. 737-742.

Research output: Contribution to journalArticle

Maeda, Takashi ; Mahara, Kazutoshi ; Kitazoe, Midori ; Futami, Junichiro ; Takidani, Aiko ; Kosaka, Megumi ; Tada, Hiroko ; Seno, Masaharu ; Yamada, Hidenori. / RNase 3 (ECP) is an extraordinarily stable protein among human pancreatic-type RNases. In: Journal of Biochemistry. 2002 ; Vol. 132, No. 5. pp. 737-742.
@article{a61bb733250a48779a103e96912d90d7,
title = "RNase 3 (ECP) is an extraordinarily stable protein among human pancreatic-type RNases",
abstract = "There have been some attempts to develop immunotoxins utilizing human RNase as a cytotoxic domain of antitumor agents. We have recently shown that only human RNase 3 (eosinophil cationic protein, ECP) among five human pancreatic-type RNases excels in binding to the cell surface and has a growth inhibition effect on several cancer cell lines, even though the RNase activity of RNase 3 is completely inhibited by the ubiquitously expressed cytosolic RNase inhibitor. This phenomenon may be explained by that RNase 3 is very stable against proteolytic degradation because RNase 3 internalized through endocytosis could have a longer life time in the cytosol, resulting in the accumulation of enough of it to exceed the concentration of RNase inhibitor, which allows the degradation of cytosolic RNA molecules. Thus, we compared the stabilities of human pancreatic-type RNases (RNases 1-5) and bovine RNase A by means of guanidium chloride-induced denaturation experiments based on the assumption of a two-state transition for unfolding. It was demonstrated that RNase 3 is extraordinarily stabler than either RNase A or the other human RNases (by more than 25 kJ/mol). Thus, our data suggest that in addition to its specific affinity for certain cancer cell lines, the stability of RNase 3 contributes to its unique cytotoxic effect and that it is important to stabilize a human RNase moiety through protein engineering for the design of human RNase-based immunotoxins. Department of Bioscience.",
keywords = "Cytotoxicity, ECP, RNase 3, Stability",
author = "Takashi Maeda and Kazutoshi Mahara and Midori Kitazoe and Junichiro Futami and Aiko Takidani and Megumi Kosaka and Hiroko Tada and Masaharu Seno and Hidenori Yamada",
year = "2002",
month = "11",
day = "1",
language = "English",
volume = "132",
pages = "737--742",
journal = "Journal of Biochemistry",
issn = "0021-924X",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - RNase 3 (ECP) is an extraordinarily stable protein among human pancreatic-type RNases

AU - Maeda, Takashi

AU - Mahara, Kazutoshi

AU - Kitazoe, Midori

AU - Futami, Junichiro

AU - Takidani, Aiko

AU - Kosaka, Megumi

AU - Tada, Hiroko

AU - Seno, Masaharu

AU - Yamada, Hidenori

PY - 2002/11/1

Y1 - 2002/11/1

N2 - There have been some attempts to develop immunotoxins utilizing human RNase as a cytotoxic domain of antitumor agents. We have recently shown that only human RNase 3 (eosinophil cationic protein, ECP) among five human pancreatic-type RNases excels in binding to the cell surface and has a growth inhibition effect on several cancer cell lines, even though the RNase activity of RNase 3 is completely inhibited by the ubiquitously expressed cytosolic RNase inhibitor. This phenomenon may be explained by that RNase 3 is very stable against proteolytic degradation because RNase 3 internalized through endocytosis could have a longer life time in the cytosol, resulting in the accumulation of enough of it to exceed the concentration of RNase inhibitor, which allows the degradation of cytosolic RNA molecules. Thus, we compared the stabilities of human pancreatic-type RNases (RNases 1-5) and bovine RNase A by means of guanidium chloride-induced denaturation experiments based on the assumption of a two-state transition for unfolding. It was demonstrated that RNase 3 is extraordinarily stabler than either RNase A or the other human RNases (by more than 25 kJ/mol). Thus, our data suggest that in addition to its specific affinity for certain cancer cell lines, the stability of RNase 3 contributes to its unique cytotoxic effect and that it is important to stabilize a human RNase moiety through protein engineering for the design of human RNase-based immunotoxins. Department of Bioscience.

AB - There have been some attempts to develop immunotoxins utilizing human RNase as a cytotoxic domain of antitumor agents. We have recently shown that only human RNase 3 (eosinophil cationic protein, ECP) among five human pancreatic-type RNases excels in binding to the cell surface and has a growth inhibition effect on several cancer cell lines, even though the RNase activity of RNase 3 is completely inhibited by the ubiquitously expressed cytosolic RNase inhibitor. This phenomenon may be explained by that RNase 3 is very stable against proteolytic degradation because RNase 3 internalized through endocytosis could have a longer life time in the cytosol, resulting in the accumulation of enough of it to exceed the concentration of RNase inhibitor, which allows the degradation of cytosolic RNA molecules. Thus, we compared the stabilities of human pancreatic-type RNases (RNases 1-5) and bovine RNase A by means of guanidium chloride-induced denaturation experiments based on the assumption of a two-state transition for unfolding. It was demonstrated that RNase 3 is extraordinarily stabler than either RNase A or the other human RNases (by more than 25 kJ/mol). Thus, our data suggest that in addition to its specific affinity for certain cancer cell lines, the stability of RNase 3 contributes to its unique cytotoxic effect and that it is important to stabilize a human RNase moiety through protein engineering for the design of human RNase-based immunotoxins. Department of Bioscience.

KW - Cytotoxicity

KW - ECP

KW - RNase 3

KW - Stability

UR - http://www.scopus.com/inward/record.url?scp=0036856265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036856265&partnerID=8YFLogxK

M3 - Article

C2 - 12417023

AN - SCOPUS:0036856265

VL - 132

SP - 737

EP - 742

JO - Journal of Biochemistry

JF - Journal of Biochemistry

SN - 0021-924X

IS - 5

ER -